Shabet Rose Sharon Insider Profile
11 Followers
Shabet Rose Sharon, Ten Percent Owner at Arbutus Biopharma, holds 16.01M shares in Arbutus Biopharma (Ticker: ABUS), holds 75.00M shares in Sio Gene Therapies (Ticker: SIOX). Most recently, Shabet Rose Sharon Bought ― shares of Arbutus Biopharma on Jul 10, 2017 for an estimated value of ―.
Shabet Rose Sharon's Trading History
| SIOXSio Gene Therapies | Jul 10, 2017 | ― | Informative Buy | ― | $35.85M | |
| ABUSArbutus Biopharma | Jul 10, 2017 | Ten Percent Owner | Informative Buy | ― | $65.50M |
You May Also Like
Shabet Rose Sharon insider profile FAQ
What is the percentage of profitable transactions made by Shabet Rose Sharon?
The percentage of profitable transactions made by Shabet Rose Sharon is 50%.
What is the average return per transaction made by Shabet Rose Sharon?
The average return per transaction made by Shabet Rose Sharon is 31.30%.
What stocks does Shabet Rose Sharon hold?
Shabet Rose Sharon holds: ABUS, SIOX stocks.
What was Shabet Rose Sharon's most profitable transaction?
Shabet Rose Sharon’s most profitable transaction was an Informative Buy of ABUS stock on July 10, 2017. The return on the trade was 151.30%.
What is Shabet Rose Sharon's role in Arbutus Biopharma?
Shabet Rose Sharon's role in Arbutus Biopharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
